USE OF AN ANTI-HUMAN TNF-ALPHA MONOCLONAL ANTIBODY IN THE MANUFACTURE OF A THERAPEUTIC FORMULATION FOR TREATING A THROMBOTIC DISORDER

摘要

A method of treating or preventing a cardiovascular and/or a cerebrovasculardisorder in an individual is disclosed. Also disclosed is a method fortreating and/or preventing a thrombotic disorder in an individual. Furtherdisclosed is a method of decreasing plasma fibrinogen in an individual.